LB Pharmaceuticals presents data on LB-102 at ECNP congress
Covered in this story
Analyst targets on Lb Pharmaceuticals Inc
- Needham: $37.3 → $68 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $LBRX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Lb Pharmaceuticals Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.